CAPITAL IMPACT ADVISORS, LLC Krystal Biotech, Inc. Transaction History

CAPITAL IMPACT ADVISORS, LLC portfolio value:

$395,000
portfolio value

CAPITAL IMPACT ADVISORS, LLC quarter portfolio value change:

+6.15%
quarter

Krystal Biotech, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +20.38% 872 shares 114K $69.7 5.15K
Q2 2022 share Increase 0.00% 4.27K shares 281K $65.66 4.27K